As of April 2024 Benitec Biopharma has a market cap of $18.12 Million. This makes Benitec Biopharma the world's 7990th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $18.12 M | 118.09% |
2023 | $8.3 M | 74.68% |
2022 | $4.75 M | -77.78% |
2021 | $21.4 M | 61.99% |
2020 | $13.21 M | -99.46% |
2019 | $2.45 B | -57.5% |
2018 | $5.78 B | -36.51% |
2017 | $9.10 B | 125.71% |
2016 | $4.03 B | -54.33% |
2015 | $8.83 B |
On Apr 19th, 2024 the market cap of Benitec Biopharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | 0.73% | Bahamas |
NRC Health
NRC | $0.81 B | 4,382.88% | ๐บ๐ธ USA |